Atea Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
AVIR chart
What traders are saying about $AVIR
Latest postsAtea Pharmaceuticals, Inc. news
- Atea Pharmaceuticals, Inc. Estimates – NASDAQ:AVIR
TradingView ·
- Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo Finance ·
- Atea (AVIR) Q2 2026 Earnings Call Transcript
fool.com ·
- Atea Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Atea Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com ·
- Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026
Yahoo Finance ·
- FDA reviewers criticize Replimune drug; ProMIS climbs on Alzheimer’s data
biopharmadive.com ·
- Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial
Yahoo Finance ·
- Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial
Yahoo Finance ·
- Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus
Yahoo Finance ·
- Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
Yahoo Finance ·
Atea Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$158.0M | -$168.0M | -$136.0M | -$116.0M |
| Diluted EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 |
| Total assets (year end) | $315.2M | $464.7M | $595.0M | $666.7M |
| Cash and equivalents (year end) | $95.7M | $64.7M | $143.8M | $188.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Atea Pharmaceuticals, Inc.
- Ticker
- AVIR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 1593899
Frequently asked questions
What exchange is Atea Pharmaceuticals, Inc. listed on?
Atea Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AVIR.
What industry is Atea Pharmaceuticals, Inc. in?
Atea Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Atea Pharmaceuticals, Inc. headquartered?
Atea Pharmaceuticals, Inc.'s business address on file with the SEC is in Boston, MA.
When does Atea Pharmaceuticals, Inc.'s fiscal year end?
Atea Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Atea Pharmaceuticals, Inc. report?
Atea Pharmaceuticals, Inc. reported $351.4M in revenue for calendar year 2021, according to its SEC filings.